Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dupilumab on Sleep Apnea Severity in Patients With Chronic Rhinosinusitis

NCT03675022 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT03675022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03675022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dupilumab on Sleep Apnea Severity in Patients With Chronic Rhinosinusitis
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 1
Overall status
Terminated
Start date
August 15, 2018
Completion date
July 1, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rhinosinusitis chronic, sleep apnea